Millions of people take medications called proton pump inhibitors, or PPIs, to relieve heartburn and acid reflux. These drugs are widely used because they can quickly reduce stomach acid and ease painful symptoms. However, new research suggests that these common medicines may also carry hidden risks, especially for the kidneys.
PPIs are among the most frequently used drugs in the world. In the United States alone, about one in ten adults takes them. Many people buy them with a prescription, while others purchase them over the counter. Well‑known brands include Prilosec, Nexium, and Prevacid.
Doctors often recommend these medicines to treat conditions such as heartburn, acid reflux, stomach ulcers, and gastroesophageal reflux disease, commonly known as GERD. GERD occurs when stomach acid repeatedly flows back into the tube that connects the mouth and stomach. This can cause burning pain in the chest, throat irritation, coughing, and trouble sleeping.
PPIs work by blocking tiny pumps in the stomach lining that produce acid. By lowering the amount of acid, they allow irritated tissues in the stomach and esophagus to heal. For many patients, these medicines greatly improve comfort and quality of life.
Despite their benefits, scientists have started to look more closely at the long‑term safety of PPIs. In recent years, researchers have reported possible links between these medications and several health problems. Among the most concerning are effects on kidney health.
A team of scientists from the University of California San Diego School of Medicine conducted a large study to investigate this issue. Their findings were published in the journal Scientific Reports. The researchers wanted to understand whether people who take PPIs may face a greater risk of kidney disease.
To do this, they analyzed information from the U.S. Food and Drug Administration’s Adverse Event Reporting System, often called FAERS. This large database collects reports from doctors, patients, and pharmaceutical companies about side effects that occur while people are taking medications. The system contains millions of records and is often used by researchers to detect possible safety concerns.
From this huge collection of reports, the research team identified about 43,000 patients who were taking proton pump inhibitors without any other medications that might affect the results. By focusing on people who used only PPIs, the scientists hoped to better understand the direct effects of these drugs.
The researchers also created a comparison group. This group included around 8,000 people who were using another type of heartburn medicine known as histamine‑2 receptor antagonists, often called H2 blockers. These drugs also reduce stomach acid, but they work in a different way.
Common examples of H2 blockers include medications such as Zantac and Pepcid. Doctors sometimes prescribe them as an alternative to PPIs, especially for milder cases of acid reflux.
When the scientists compared the two groups, they noticed an important difference. Kidney‑related side effects were reported far more often among people who used PPIs alone. About 5.6 percent of PPI users reported kidney problems, compared with only 0.7 percent of those who used H2 blockers.
The study found that people taking PPIs had a much higher likelihood of reporting several serious kidney conditions. These included chronic kidney disease, acute kidney injury, and end‑stage renal disease, which is the most severe form of kidney failure and often requires dialysis or a kidney transplant.
In the analysis, people using PPIs were about 28 times more likely to report chronic kidney disease than those using H2 blockers. They were also more than four times more likely to report acute kidney injury and more than 35 times more likely to report end‑stage kidney disease.
The researchers also observed reports of electrolyte imbalances. Electrolytes are minerals in the body that help control fluid balance, nerve signals, and muscle function. When these levels become abnormal, it can affect many organs, including the kidneys.
Interestingly, the increased kidney risk appeared across all five PPI medications included in the study. In contrast, the risk was much lower and more stable among patients using H2 blockers.
The scientists noted that this type of study cannot prove that PPIs directly cause kidney disease. The FAERS database relies on voluntary reports, which means the information may not capture every case. However, the strong pattern seen in the data suggests that the link deserves careful attention and further investigation.
Health experts say patients should not stop taking prescribed medications suddenly without talking to their doctor. For many people, PPIs are still very effective and necessary for controlling severe acid‑related conditions.
However, the findings highlight the importance of using these medicines carefully. Doctors may want to prescribe the lowest effective dose and review whether patients still need the medication during long‑term treatment.
The study also encourages doctors to discuss possible risks with patients, particularly those who already have kidney problems or other health conditions that may increase their risk.
Earlier research has raised other concerns about proton pump inhibitors as well. A study published in 2017 by researchers at UC San Diego suggested that long‑term PPI use might also be linked to chronic liver disease. These findings suggest that the effects of these medications may extend beyond the stomach.
For people who frequently experience heartburn or reflux, lifestyle changes may also help reduce symptoms. Eating smaller meals, avoiding late‑night eating, limiting alcohol, quitting smoking, and maintaining a healthy weight can all reduce acid reflux.
Regular medical checkups are also important, especially for people who use PPIs for long periods. Blood tests and urine tests can help doctors monitor kidney function and detect problems early.
Overall, the research serves as a reminder that even very common medicines should be used thoughtfully. While proton pump inhibitors provide important relief for millions of people, both doctors and patients should carefully balance their benefits and possible risks.
If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and drinking coffee could help reduce risk of kidney injury.
For more information about kidney health, please see recent studies about foods that may prevent recurrence of kidney stones, and eating nuts linked to lower risk of chronic kidney disease and death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
